
Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Total monthly reach
Estimated from 1 chart position in 1 market.
By chart position
- 🇺🇸US · Life Sciences#8530K to 100K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
9K to 30K🎙 Daily cadence·6 episodes·Last published today - Monthly Reach
Unique listeners across all episodes (30 days)
30K to 100K🇺🇸100% - Active Followers
Loyal subscribers who consistently listen
12K to 40K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
Recent episodes
Episode 9: Mitochondria, Machine Learning, and a Few Hard Lessons
May 20, 2026
Unknown duration
Episode 8: The Equity Gap in Diagnostic AI
May 13, 2026
Unknown duration
Episode 7: AI at the Bench: The New Wet Lab Workflow
May 6, 2026
Unknown duration
Episode 6: Digital Twins, Real-World Evidence, and the Future of Clinical Trials
Apr 29, 2026
Unknown duration
Episode 5: Animal Genomics, AI, and the Future of Space Travel
Apr 15, 2026
Unknown duration
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Description | Length | |
|---|---|---|---|---|
| 5/20/26 | ![]() Episode 9: Mitochondria, Machine Learning, and a Few Hard Lessons | Rachel Jacobson has spent her career moving between some of the most demanding corners of life sciences before founding Powerhouse Biology. In this episode, she traces that journey and explains why, after all of it, she keeps coming back to mitochondria. We get into what it actually takes to bridge biology and machine learning inside a lab culture, why asking "stupid questions" across disciplines is a feature and not a bug, and what she had to unlearn from traditional drug development to work effectively alongside ML engineers.We also dig into data design. Rachel makes a sharp case that data passing standard biological QC is not the same as data that's ready for a machine learning model. Uneven plate layouts, cell debris, different scientists handling samples can all create batch effects that quietly break your model before it ever sees a hypothesis worth testing. She connects all of this to a bigger argument about why human biological variability needs to be built into preclinical pipelines from the start, and why ML might finally give scientists the tools to do that seriously. | — | |
| 5/13/26 | ![]() Episode 8: The Equity Gap in Diagnostic AI | In this episode, we sit down with Dr. Freddy Nguyen, CEO and co-founder of Nine Diagnostics, whose background spans medicine, pathology, optics, and nanotechnology. Freddy shares how Nine Diagnostics is building a multiomics platform that helps cancer patients find out within days whether their treatment is actually working. We dig into why AI's real power in medicine lies in its ability to connect siloed data across molecular readouts, imaging, and clinical context, and why treating patients as more than just their diagnosis is the only way to build tools that actually hold up in the real world. We also get into the harder conversation: where AI in clinical workflows breaks down. It's a candid, technically grounded conversation about what equitable AI in medicine actually requires. | — | |
| 5/6/26 | ![]() Episode 7: AI at the Bench: The New Wet Lab Workflow | In this episode of From Models to Medicine, we sit down with Elisa Martin Perez, a postdoc at University of California, Berkeley, to talk about how non-coders are starting to use AI in their day-to-day work. From learning R through conversation to making sense of massive CRISPR screens, Elisa shares how AI is becoming a practical tool for navigating data, checking experimental design, and cutting down on the kinds of manual tasks that quietly consume hours in the lab.We also get into the hesitation many scientists feel around adopting AI, where the technology actually helps (and where it doesn’t), and why it still falls short of running experiments end-to-end. Along the way, we touch on lab logistics, data overload, and what it means to use AI as a thinking partner rather than a replacement. | — | |
| 4/29/26 | ![]() Episode 6: Digital Twins, Real-World Evidence, and the Future of Clinical Trials | What does it actually take to make AI work inside a pharmaceutical company and why do so many efforts stall after the model is built? Pranay Mohanty, from J&J Innovative Medicine, joins us to talk about how building the model is only one part of the work and what can happen when you try to apply that model to messy, real-world data.We dig into how teams are starting to use digital twins to simulate patients and rethink trial design, what it looks like to work alongside regulators like the U.S. Food and Drug Administration, and why keeping a human in the loop isn’t optional. Along the way, we share how AI is actually shaping portfolio decisions today and where the limits still are. | — | |
| 4/15/26 | ![]() Episode 5: Animal Genomics, AI, and the Future of Space Travel | In this episode of From Models to Medicine, we sit down with Ashley Zehnder, the founder of Fauna Bio to explore one of the most creative bets in drug discovery: using extreme animal biology to unlock human therapeutics. We dig into the graph neural networks powering Fauna Bio's drug discovery platform, the unglamorous data curation work that makes it all function, and why human-in-the-loop isn't a limitation but a design principle. Plus: what hibernation research could mean for long-duration human space travel. | — | |
| 4/8/26 | ![]() Episode 4: Your Clinical Brain is an AI Superpower | What does emergency medicine have to do with large-scale knowledge systems? Jason Grafft joins us to talk about his non-linear path from EMS and simulation education to knowledge engineering and why the structured, fact-bound thinking that medicine demands is one of the most undervalued assets in the AI era. We dig into how he uses graph-based models to bridge clinical experts and technical systems, where LLMs are actually helping in entity resolution, and the practical advice he gives every clinician trying to break into tech. | — | |
| 4/1/26 | ![]() Episode 3: Limitations of AI in Life Sciences | In this episode of From Models to Medicine, we sit down with Rachel Thomas to discuss the growing gap between AI hype and scientific reality in the life sciences. The conversation highlights the hidden costs of poor data quality and the necessity of domain expertise, featuring deep dives into real-world AI missteps, from a flawed enzyme classification paper to an app's mishandling of long-COVID data. | — | |
| 3/25/26 | ![]() Episode 2: A Pathologist's Guide to the AI Transition | As pathology labs digitize, how do skilled practitioners learn to trust AI with patient diagnoses? Michael Rivers discusses the critical importance of "explainable AI," keeping the human pathologist in the loop with the ability to override algorithms, and how these powerful new technologies will help address the global shortage of pathologists, ultimately bringing equitable, expert care to patients worldwide. | — | |
| 3/18/26 | ![]() Episode 1: Are Models Really Models? | Join us in our first episode where we chat with Margo Georgiadis, CEO of Montai Therapeutics as we discuss what a model means in ML vs. life sciences and how she's been able to bridge the knowledge gap between these two practices for her team. | — | |
| 3/13/26 | ![]() Podcast Trailer: Welcome to From Models to Medicine | Welcome to From Model to Medicine, a podcast from KAMI Think Tank exploring how artificial intelligence is actually being applied across the life sciences industry.Each episode, we speak with scientists, operators, and leaders working at the intersection of AI and biology, from drug discovery and clinical development to regulatory operations and beyond.KAMI Think Tank is an educational organization that helps life science professionals learn how to use AI practically in their day-to-day work.This podcast is about moving past the hype and understanding what it actually takes to bring AI from promising models to real impact in medicine.We’re your hosts, Kamayani Gupta and Michelle Yi. This is From Model to Medicine. | — |
Showing 10 of 10
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
1 placement across 1 market.
Chart Positions
1 placement across 1 market.
